Net profit of the Human Stem Cells Institute according to RAS for 6 months of 2020 amounted to ₽1,171 million, which is 88 times lower than the previous year's profit of ₽103,073 million. Revenue decreased by 32.4% to ₽26,922 million as compared to ₽39,854 million a year earlier.